On August 4, 2021, a walk-in vaccine clinic inside a Buddhist temple in the Smithfield suburb of Sydney will be open.
Some people who receive the Oxford-AstraZeneca Covid vaccine may be at risk for blood clot.
Some countries have restricted the use of the vaccine for older adults because of the link between it and blood clot risks.
The benefits of the vaccine outweigh the risks, with one study concluding that Covid-19 poses a much bigger threat of blood clot than vaccination.
The scientists from the U.K. and Arizona State University collaborated with the pharma company to investigate vaccine-caused blood clot.
The study suggested that the vaccine could be the problem.
The adenoviruses found in Chimpanzees are found in the Oxford-AstraZeneca vaccine. A key part of the structure of the adenoviruses is the spike protein.
The Covid-19 vaccine uses an adenoviruses to carry spike proteins from the coronaviruses into human cells to cause an immune response and has been linked to rare blood clot.
The team behind the study believed that the vaccine could prompt the body to act against itself.
In rare cases, the Oxford-AstraZeneca vaccine can bind to a platelet factor 4 in the bloodstream.
The authors of the study said that the immune system views the vaccine as foreign once it is bound to the protein. The release of antibodies against PF4 may cause the cells that help clot to cluster together and cause blood clot.
The authors of the study said that the phenomenon occurs in a very small number of people.
If a procedure is established to prevent and treat the rare vaccine-caused blood clot, it may help to prevent and treat the disorder.
He said in a press release Wednesday that vaccine-induced immune thrombotic thrombocytopenia is only rare in extremely rare cases.
We hope our findings can be used to better understand the rare side effects of these new vaccines, and potentially to design new and improved vaccines to turn the tide on this global pandemic.
